These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 34014579)

  • 1. Subungual squamous cell carcinoma in a BAP1 germline pathogenic variant carrier.
    Idoudi S; Bressac-de Paillerets B; Balme B; Bonnet-Dupeyron MN; Golmard L; Thomas L
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e665-e667. PubMed ID: 34014579
    [No Abstract]   [Full Text] [Related]  

  • 2. Germline BAP1 mutations also predispose to cutaneous squamous cell carcinoma.
    Rawson RV; Watson GF; Maher AM; McCarthy SW; Thompson JF; Scolyer RA
    Pathology; 2017 Aug; 49(5):539-542. PubMed ID: 28693747
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of germline BAP1 mutation in a population-based sample of uveal melanoma cases.
    Aoude LG; Vajdic CM; Kricker A; Armstrong B; Hayward NK
    Pigment Cell Melanoma Res; 2013 Mar; 26(2):278-9. PubMed ID: 23171164
    [No Abstract]   [Full Text] [Related]  

  • 4. BAP1 Germline Mutations in Finnish Patients with Uveal Melanoma.
    Turunen JA; Markkinen S; Wilska R; Saarinen S; Raivio V; Täll M; Lehesjoki AE; Kivelä TT
    Ophthalmology; 2016 May; 123(5):1112-7. PubMed ID: 26876698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of BAP1 Germline Gene Mutation in Young Uveal Melanoma Patients.
    Cebulla CM; Binkley EM; Pilarski R; Massengill JB; Rai K; Liebner DA; Marino MJ; Singh AD; Abdel-Rahman MH
    Ophthalmic Genet; 2015 Jun; 36(2):126-31. PubMed ID: 25687217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations.
    Zauderer MG; Jayakumaran G; DuBoff M; Zhang L; Francis JH; Abramson DH; Cercek A; Nash GM; Shoushtari A; Chapman P; D'Angelo S; Arnold AG; Siegel B; Fleischut MH; Ni A; Rimner A; Rusch VW; Adusumilli PS; Travis W; Sauter JL; Zehir A; Mandelker D; Ladanyi M; Robson M
    J Thorac Oncol; 2019 Nov; 14(11):1989-1994. PubMed ID: 31323388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based analysis of BAP1 germline variations in patients with uveal melanoma.
    Repo P; Järvinen RS; Jäntti JE; Markkinen S; Täll M; Raivio V; Turunen JA; Kivelä TT
    Hum Mol Genet; 2019 Jul; 28(14):2415-2426. PubMed ID: 31058963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAP1 germline mutation in two first grade family members with uveal melanoma.
    Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H
    Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uveal Melanoma in BAP1 Tumor Predisposition Syndrome: Estimation of Risk.
    Singh N; Singh R; Bowen RC; Abdel-Rahman MH; Singh AD
    Am J Ophthalmol; 2021 Apr; 224():172-177. PubMed ID: 33316260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline BAP1 mutations misreported as somatic based on tumor-only testing.
    Abdel-Rahman MH; Rai K; Pilarski R; Davidorf FH; Cebulla CM
    Fam Cancer; 2016 Apr; 15(2):327-30. PubMed ID: 26748926
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Helgadottir H; Schultz K; Lapins J; Vassilaki I; All-Eriksson C; Höiom V
    Acta Oncol; 2023 Jun; 62(6):565-570. PubMed ID: 37265265
    [No Abstract]   [Full Text] [Related]  

  • 12. Loss of expression of BAP1 is very rare in non-small cell lung carcinoma.
    Andrici J; Parkhill TR; Jung J; Wardell KL; Verdonk B; Singh A; Sioson L; Clarkson A; Watson N; Sheen A; Farzin M; Toon CW; Gill AJ
    Pathology; 2016 Jun; 48(4):336-40. PubMed ID: 27114369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline BAP1 alterations in familial uveal melanoma.
    Rai K; Pilarski R; Boru G; Rehman M; Saqr AH; Massengill JB; Singh A; Marino MJ; Davidorf FH; Cebulla CM; H Abdel-Rahman M
    Genes Chromosomes Cancer; 2017 Feb; 56(2):168-174. PubMed ID: 27718540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations.
    Gupta MP; Lane AM; DeAngelis MM; Mayne K; Crabtree M; Gragoudas ES; Kim IK
    JAMA Ophthalmol; 2015 Aug; 133(8):881-7. PubMed ID: 25974357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional assay for assessment of pathogenicity of BAP1 variants.
    Repo PE; Backlund MP; Kivelä TT; Turunen JA
    Hum Mol Genet; 2024 Feb; 33(5):426-434. PubMed ID: 37956408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal cell carcinomas developing independently from BAP1-tumor predisposition syndrome in a patient with bilateral uveal melanoma: Diagnostic challenges to identify patients with BAP1-TPDS.
    Melzer C; Sharma A; Peters S; Aretz S; Biswas A; Holz FG; Loeffler KU; Herwig-Carl MC
    Genes Chromosomes Cancer; 2019 Jun; 58(6):357-364. PubMed ID: 30578689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic cholangiocarcinoma development in a patient with a novel BAP1 germline mutation and low exposure to asbestos.
    Brandi G; Deserti M; Palloni A; Turchetti D; Zuntini R; Pedica F; Frega G; De Lorenzo S; Abbati F; Rizzo A; Di Marco M; Massari F; Tavolari S
    Cancer Genet; 2020 Oct; 248-249():57-62. PubMed ID: 33093002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes.
    Betti M; Aspesi A; Ferrante D; Sculco M; Righi L; Mirabelli D; Napoli F; Rondón-Lagos M; Casalone E; Vignolo Lutati F; Ogliara P; Bironzo P; Gironi CL; Savoia P; Maffè A; Ungari S; Grosso F; Libener R; Boldorini R; Valiante M; Pasini B; Matullo G; Scagliotti G; Magnani C; Dianzani I
    Genes Chromosomes Cancer; 2018 Nov; 57(11):573-583. PubMed ID: 30338612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline mutation in the TP53 gene in uveal melanoma.
    Hajkova N; Hojny J; Nemejcova K; Dundr P; Ulrych J; Jirsova K; Glezgova J; Ticha I
    Sci Rep; 2018 May; 8(1):7618. PubMed ID: 29769598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic BAP1 Loss in Ovarian Serous Borderline Tumor and Recurrent Low-grade Serous Carcinoma From a Germline BAP1 Mutation Carrier.
    Chui MH; Grisham RN
    Int J Gynecol Pathol; 2023 Jul; 42(4):432-433. PubMed ID: 36867467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.